Search

everythinglearnresearchcommunity

for

Search:↓

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

A dog fully recovered from minoxidil poisoning after receiving treatment.

Gray hair can potentially be reversed, leading to new treatments.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

The symposium highlighted the skin's role in sensing itch, pain, touch, and pleasure, and discussed new research and techniques for understanding and treating these sensations.

The document concludes that a new treatment for a type of hair loss called telogen effluvium was tested and shows promise.

Stress may trigger hair loss by affecting immune protection in hair follicles.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Stress in mice delays hair growth and treatments blocking substance P can partly reverse this effect.

The skin acts like an endocrine organ, making hormones that affect skin diseases and respond to stress.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Certain brain hormones and chemicals are linked to the development of Polycystic Ovary Syndrome.

A 19-year-old male with delayed puberty was successfully treated for a condition that prevents normal hormone production.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Excess androgens may cause PCOS, not just be a symptom.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Stress stops hair growth in mice by causing early hair growth phase end and harmful inflammation through a specific nerve-related pathway.

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

SM-215 promotes hair growth by improving the environment around hair follicles.

Some migraine sufferers had no more headaches after getting a hair transplant.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

The document explains how male reproductive hormones work and affect the body.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.